85 related articles for article (PubMed ID: 2796861)
21. The therapeutic potential of the proteasome in leukaemia.
McCloskey SM; McMullin MF; Walker B; Irvine AE
Hematol Oncol; 2008 Jun; 26(2):73-81. PubMed ID: 18324639
[TBL] [Abstract][Full Text] [Related]
22. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
Perez A; Kennedy C; Standen G; Oxley J
Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
[TBL] [Abstract][Full Text] [Related]
23. The conundrum of cancer: 50 issues of The Lancet Oncology.
Lee JA
Lancet Oncol; 2004 Oct; 5(10):589-90. PubMed ID: 15487120
[No Abstract] [Full Text] [Related]
24. Imatinib mesylate therapy in chronic myeloid leukaemia: the floodgates opened.
Agarwal MB
J Assoc Physicians India; 2007 Feb; 55():99-100. PubMed ID: 17571737
[No Abstract] [Full Text] [Related]
25. Leukemia research, 2008.
Freireich EJ; Kantarjian H; Keating MJ
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S178. PubMed ID: 19778837
[No Abstract] [Full Text] [Related]
26. Oncology in transition: the pivotal role of the American Society of Clinical Oncology.
Glick JH
Trans Am Clin Climatol Assoc; 1997; 108():245-55; discussion 255-8. PubMed ID: 9108681
[No Abstract] [Full Text] [Related]
27. The curse of the cure.
DeVita VT
Nat Clin Pract Oncol; 2005 Jan; 2(1):1. PubMed ID: 16264829
[No Abstract] [Full Text] [Related]
28. [The French Society of Oncology].
Jacquemin-Sablon A
Bull Cancer; 1997 Jan; 84(1):5. PubMed ID: 9180850
[No Abstract] [Full Text] [Related]
29. Modeling a description logic vocabulary for cancer research.
Hartel FW; de Coronado S; Dionne R; Fragoso G; Golbeck J
J Biomed Inform; 2005 Apr; 38(2):114-29. PubMed ID: 15797001
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Oncology Groups in Japan: experience of the Japan Adult Leukemia Study Group (JALSG)].
Ohno R
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2519-24. PubMed ID: 8279850
[TBL] [Abstract][Full Text] [Related]
31. Recording clinical data--from a general set of record items to case report forms (CRF) for clinics.
Merzweiler A; Knaup P; Weber R; Ehlerding H; Haux R; Wiedemann T
Stud Health Technol Inform; 2001; 84(Pt 1):653-7. PubMed ID: 11604818
[TBL] [Abstract][Full Text] [Related]
32. [The French Society if Oncology].
Jeanteur P
Bull Cancer; 1997 Jan; 84(1):6. PubMed ID: 9180851
[No Abstract] [Full Text] [Related]
33. Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.
Vincent S; Djulbegovic B
Cancer Treat Rev; 2005 Jun; 31(4):319-22. PubMed ID: 16006047
[No Abstract] [Full Text] [Related]
34. Hematological Oncology: further ahead.
Bertoni F
Hematol Oncol; 2008 Mar; 26(1):1-2. PubMed ID: 18307253
[TBL] [Abstract][Full Text] [Related]
35. Requirements and design aspects of a data model for a data dictionary in paediatric oncology.
Merzweiler A; Knaup P; Creutzig U; Ehlerding H; Haux R; Mludek V; Schilling FH; Weber R; Wiedemann T
Stud Health Technol Inform; 2000; 77():696-700. PubMed ID: 11187643
[TBL] [Abstract][Full Text] [Related]
36. The real impact of oral oncology.
Scully C
Oral Oncol; 2008 May; 44(5):423-4. PubMed ID: 18439869
[No Abstract] [Full Text] [Related]
37. Leukaemia cutis: clinical features and treatment strategies.
Zweegman S; Vermeer MH; Bekkink MW; van der Valk P; Nanayakkara P; Ossenkoppele GJ
Haematologica; 2002 Apr; 87(4):ECR13. PubMed ID: 11940495
[No Abstract] [Full Text] [Related]
38. [The present status and prospects for clinical oncology in Japan].
Oshita F; Saijo N
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():281-8. PubMed ID: 7986104
[TBL] [Abstract][Full Text] [Related]
39. Serving interests in hematologic malignancies in the journal of clinical oncology.
Cheson BD; Haller D; Horning SJ
J Clin Oncol; 2005 Jun; 23(16):3666-7. PubMed ID: 15923567
[No Abstract] [Full Text] [Related]
40. "Experimental oncology": achievements and prospects for the future.
Chekhun V
Eksp Onkol; 2004 Mar; 26(1):2. PubMed ID: 15112571
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
